With funds from NIH, Barbara Nikolajczyk is tracking the trajectory of type 2 diabetes. She's following metabolically healthy people as they naturally progress to diabetes, looking for potential drug targets along the way.
With the Markey Cancer Center, Ellingson uses molecular docking as a filtering process to efficiently and safely screen potential drugs before real-world experiments begin.
This project will collect, transcribe, edit and publish the complete writings of Dickinson, who wrote more for the American cause than any other founding father.
